January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The disposable safety lancet market thrives on diagnostics like cholesterol and diabetes monitoring. BeatO secured $33 million in November 2024 for its glucose tracking app, while Biolinq raised $58 million in April 2024 for a glucose-monitoring device that uses a retractable needle, enhancing safety and accuracy....
April 21, 2026
According to market projections, the pharmaceutical CDMO sector is expected to grow from USD 167.96 billion in 2025 to USD 337.89 billion by 2035, reflecting a CAGR of 7.24%. Pharma companies face challenges in researching and manufacturing new therapies. Partnering with a CDMO helps by offering expertise, scalability, and cost savings....
April 21, 2026
Optical imaging uses light to capture detailed images of the body, reducing the need for harmful X-rays. It’s effective for visualizing soft tissues and includes techniques like endoscopy, OCT, and Raman spectroscopy. Recent advancements, like Nano-based agents and new partnerships, are boosting the market....
April 21, 2026
Diabetes affects millions worldwide, with over 422 million people impacted. The rise in diabetes, especially Type 2, is driving demand for devices like diabetic lancets, which help monitor blood glucose levels. With a growing elderly population and increasing awareness, the market for these devices is expanding globally....
April 21, 2026
Cord blood, collected from the umbilical cord after birth, contains stem cells that treat various disorders. Cord blood banks offer storage options for family-only access (private banks) or public use. Rising cases of cancers and genetic disorders drive demand, alongside new initiatives enhancing storage and treatment access....
April 21, 2026
According to market projections, the compounding pharmacy sector is expected to grow from USD 13.86 billion in 2024 to USD 22.91 billion by 2034, reflecting a CAGR of 5.15%, tailoring medications for unique patient needs, such as dye allergies or non-pill forms. Valor Compounding Pharmacy and Revelation Pharma recently expanded through partnerships...
April 21, 2026
Androgenetic alopecia, a genetic condition causing gradual hair loss, affects up to 50% of men and women, with Caucasians showing the highest prevalence. In 2024, Pelage Pharmaceuticals raised $16.75M for hair loss therapies, while a company raised $4M to treat this genetic condition....
April 21, 2026
The immunodiagnostics market is growing with innovations like ELISA, CLIA, and fluorescent immunoassays. The National Institute of Biologicals and regulatory bodies oversee quality and safety for diagnostics, while companies like Thermo Fisher and Serum Institute advance solutions for disease detection and research....
April 21, 2026
The insulin delivery system market is expanding rapidly as diabetes rates rise due to lifestyle and population trends. Key players aim to provide affordable, user-friendly solutions. Notable developments include FDA approvals for innovative devices and AI-driven technologies that enhance personalized care....
April 21, 2026
Biosimulation uses computer models to mimic biological systems, aiding drug development without testing on humans or animals. It predicts drug responses, toxicity, and effectiveness, speeding up R&D. Rising chronic diseases, R&D investments, and tech advancements are driving biosimulation demand....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
